Dr. Steven Rosen from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago, expresses his excitement for the encouraging advancements and understanding of blood cancer treatments presented at the recent annual American Society of Hematology conference. Dr. Rosen explains one of the key factors is understanding the genetics of each individual's cancer to determine the best treatment course. As survivorship increases, the paradigm is shifting to a long term care disease management while still maintaining quality of life.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…